0.68 - 0.75
0.33 - 0.86
18.36M / 4.66M (Avg.)
34.50 | 0.02
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
35.47%
Operating income growth above 1.5x 0425.HK's 9.99%. David Dodd would confirm if consistent cost or pricing advantages drive this outperformance.
-97.68%
Negative net income growth while 0425.HK stands at 8.40%. Joel Greenblatt would push for a reevaluation of cost or revenue strategies.
-97.61%
Negative EPS growth while 0425.HK is at 10.53%. Joel Greenblatt would expect urgent managerial action on costs or revenue drivers.
-97.61%
Negative diluted EPS growth while 0425.HK is at 10.53%. Joel Greenblatt would require immediate efforts to restrain share issuance or boost net income.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
34936.17%
10Y revenue/share CAGR above 1.5x 0425.HK's 935.92%. David Dodd would confirm if management’s strategic vision consistently outperforms the competitor.
39780.80%
5Y revenue/share CAGR above 1.5x 0425.HK's 247.27%. David Dodd would look for consistent product or market expansions fueling outperformance.
11.69%
3Y revenue/share CAGR under 50% of 0425.HK's 94.36%. Michael Burry might see a serious short-term decline in relevance vs. the competitor.
-62.82%
Negative 10Y OCF/share CAGR while 0425.HK stands at 1679.87%. Joel Greenblatt would scrutinize managerial effectiveness and product competitiveness.
532.01%
5Y OCF/share CAGR above 1.5x 0425.HK's 148.44%. David Dodd would confirm if the firm has better cost structures or brand premium boosting mid-term cash flow.
-96.14%
Negative 3Y OCF/share CAGR while 0425.HK stands at 37.77%. Joel Greenblatt would demand an urgent turnaround in the firm’s cost or revenue drivers.
103.33%
Below 50% of 0425.HK's 587.67%. Michael Burry would worry about a sizable gap in long-term profitability gains vs. the competitor.
-91.27%
Negative 5Y net income/share CAGR while 0425.HK is 149.89%. Joel Greenblatt would see fundamental missteps limiting profitability vs. the competitor.
103.23%
3Y net income/share CAGR 1.25-1.5x 0425.HK's 93.17%. Bruce Berkowitz might see new markets, M&A, or better cost discipline driving the difference.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
141.40%
3Y equity/share CAGR above 1.5x 0425.HK's 64.19%. David Dodd verifies the company’s short-term capital management far exceeds the competitor’s pace.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-32.98%
Negative near-term dividend growth while 0425.HK invests at 104.82%. Joel Greenblatt sees a weaker short-term distribution policy unless justified by strategic spending.
No Data
No Data available this quarter, please select a different quarter.
-8.56%
Both reduce inventory yoy. Martin Whitman suspects a broader move to lean operations or industry slowdown in demand.
3.42%
Asset growth well under 50% of 0425.HK's 10.60%. Michael Burry sees the competitor as far more aggressive in building resources or capacity.
11.97%
BV/share growth above 1.5x 0425.HK's 6.74%. David Dodd confirms if consistent profit retention or fewer write-downs yield faster equity creation.
144.87%
Debt growth far above 0425.HK's 39.47%. Michael Burry fears the firm is taking on undue leverage vs. the competitor.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.